AstraZeneca's Imfinzi perioperative regimen improved survival outcomes in muscle-invasive bladder cancer, with FDA Priority ...

The first change is obvious: The parents and public personalities who strongly oppose vaccines have gotten louder. They have ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 59 tables and 54 figures, this 141-page report ?Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, ...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

COVID Vaccines Linked to Autoimmune Disease** In a groundbreaking development, recent research has unveiled that COVID-19 vaccines may act as a trigger for ...

Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...

Pharmaceutical giant AstraZeneca has axed plans to invest £450m in expanding its vaccine manufacturing warehouse in Speke, ...

Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase III trial results which ...

They will be followed by vaccine safety experts Professor Dani Prieto ... global product lead at AstraZeneca. Public hearings for module four of the Covid-19 Inquiry will run until January 31.